Great West Life Assurance CO Regeneron Pharmaceuticals, Inc. Transaction History
Great West Life Assurance CO
- $53.1 Billion
- Q2 2024
A detailed history of Great West Life Assurance CO transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 120,091 shares of REGN stock, worth $122 Million. This represents 0.24% of its overall portfolio holdings.
Number of Shares
120,091
Previous 101,164
18.71%
Holding current value
$122 Million
Previous $97.4 Million
29.63%
% of portfolio
0.24%
Previous 0.2%
Shares
29 transactions
Others Institutions Holding REGN
# of Institutions
1,464Shares Held
84.4MCall Options Held
907KPut Options Held
1.3M-
Vanguard Group Inc Valley Forge, PA8.99MShares$9.11 Billion0.18% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$8.55 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY8.28MShares$8.38 Billion0.77% of portfolio
-
State Street Corp Boston, MA4.84MShares$4.9 Billion0.23% of portfolio
-
Capital World Investors Los Angeles, CA4.64MShares$4.7 Billion0.82% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $109B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...